Literature DB >> 7019404

Demonstration of normal plasma somatomedin concentrations in cystic fibrosis.

R G Rosenfeld, C Landon, N Lewiston, R Nagashima, R L Hintz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7019404     DOI： 10.1016/s0022-3476(81)80467-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 2.  [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors:  E Weimann; W Kiess
Journal:  Klin Wochenschr       Date:  1990-10-17

3.  Diminished concentrations of insulin-like growth factor I in cystic fibrosis.

Authors:  E M Laursen; A Juul; S Lanng; N Høiby; C Koch; J Müller; N E Skakkebaek
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

4.  Growth failure and treatment in cystic fibrosis.

Authors:  Trang N Le; Abeer Anabtawi; Melissa S Putman; Vin Tangpricha; Michael S Stalvey
Journal:  J Cyst Fibros       Date:  2019-10       Impact factor: 5.482
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.